Bixby Bridge, BigSur, California, USA

Facts & Highlights

over

$90M

of public and private funding,
$50M of which is dedicated to R&D

5

pharma partnerships
AstraZeneca, Pfizer, GlaxoSmithKline,
Janssen, Purdue

14

strategic and research partnerships
with university centres, hospitals, and
biotechnology societies

Portfolio with

8

innovative projects
at different stages of development
(lead generation to clinical proof of concept)
and targeting various indications
(oncology, cardiovascular, pain, infectious diseases)

3

clinical programs
targeting unmet medical needs

2

exceptional facilities
supporting drug discovery efforts; one in
Saint-Laurent in the field of small chemical molecules, and the other in Laval in the field of biologics and vaccines

32
independent businesses
employing 350 people and offering services
in medicinal chemistry, biological test development, pharmacokinetics, and metabolism, etc.

1
Spin-off Company
dedicated to the advancement of unique and potent epigenetic inhibitors for the targeted treatment of cancer.

© 2018 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia